Cantor Fitzgerald Analysts Boost Earnings Estimates for VERV
Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) – Research analysts at Cantor Fitzgerald boosted their FY2025 earnings per share estimates for shares of Verve Therapeutics in a research note issued on Thursday, May 15th. Cantor Fitzgerald analyst R. Bienkowski now forecasts that the company will post earnings of ($2.16) per share for the year, up […]
Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) – Research analysts at Cantor Fitzgerald boosted their FY2025 earnings per share estimates for shares of Verve Therapeutics in a research note issued on Thursday, May 15th. Cantor Fitzgerald analyst R. Bienkowski now forecasts that the company will post earnings of ($2.16) per share for the year, up […]
